Skip to main content
. Author manuscript; available in PMC: 2014 Feb 1.
Published in final edited form as: Br J Haematol. 2012 Dec 13;160(4):530–537. doi: 10.1111/bjh.12163

Figure 4. Overall survival based on tissue factor-bearing microparticle status.

Figure 4

Median survival for study subjects with higher concentration of tissue factor-bearing microparticles (TFMP) on observation (blue) was 11.8 months compared with 17.8 months on enoxaparin (green, Log-rank test P-value=0.58). The median survival for lower tissue factor-bearing microparticle arm was 17.3 months (red).